Sandra Milligan - May 1, 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of Research & Development
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Stock symbol
OGN
Transactions as of
May 1, 2022
Transactions value $
-$17,458
Form type
4
Date filed
5/3/2022, 07:40 PM
Previous filing
Apr 4, 2022
Next filing
May 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +1.9K +20.21% 11.3K May 1, 2022 Direct F1
transaction OGN Common Stock Tax liability -$17.5K -540 -4.79% $32.33 10.7K May 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -1.9K -50% $0.00 1.9K May 1, 2022 Common Stock 1.9K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023.
F2 The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.